UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Tissue inhibitor of metalloproteinases-1 in breast cancer

Endocrine-related cancer, 2005-06, Vol.12 (2), p.215-227

2005

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of sample handling in relation to levels of tissue inhibitor of metalloproteinases-1 measured in blood by immunoassay

The International journal of biological markers, 2003-07, Vol.18 (3), p.170-176

2003

Link zum Volltext

Verfügbarkeit prüfen

Investigation of tissue inhibitor of metalloproteinases 1 in plasma from colorectal cancer patients and blood donors by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry

The International journal of biological markers, 2007-04, Vol.22 (2), p.89-94

2007

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of sample handling in relation to levels of tissue inhibitor of metalloproteinases-1 measured in blood by immunoassay

The International journal of biological markers, 2003, Vol.18 (3), p.170-176

2003

Link zum Volltext

Verfügbarkeit prüfen

Levels of tissue inhibitor of metalloproteinases 1 in plasma and urine from patients with bladder cancer

The International journal of biological markers, 2006, Vol.21 (1), p.6-11

2006

Link zum Volltext

Verfügbarkeit prüfen

Tissue inhibitor of metalloproteinases-1 protects the human breast carcinoma cell line MCF-7 S1 against anthracycline-induced cell death by activation of the akt survival pathway

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.2019

2009

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-07-04: Preoperative Plasma Concentration of MMP-9/TIMP-1 Complexes Is Not Associated with Disease Outcome in Primary Breast Cancer (N=483)

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P4-P4-07-04

2010

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-08-08: Cross Reactivity of Clinically Validated Anti-HER2 Antibodies

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P4-P4-08-08

2010

Link zum Volltext

Verfügbarkeit prüfen

Tumor Tissue Levels of Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Marker in Primary Breast Cancer

Clinical cancer research, 2004-04, Vol.10 (7), p.2289-2298

2004

Link zum Volltext

Verfügbarkeit prüfen

Tumor tissue levels of tissue inhibitor of metalloproteinases-1 (TIMP-1) and survival following adjuvant chemotherapy in pre-menopausal lymph node-positive breast cancer patients (N=525)

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.6054

2009

Link zum Volltext

Verfügbarkeit prüfen

Validation of the predictive value of tissue inhibitor of metalloproteinases-1 for the response to first-line chemotherapy in metastatic breast cancer

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.6057

2009

Link zum Volltext

Verfügbarkeit prüfen

Tumor markers: from laboratory to clinical utility

Molecular & cellular proteomics, 2003-06, Vol.2 (6), p.378-387

2003

Link zum Volltext

Verfügbarkeit prüfen

Tumor Tissue Concentrations of the Proteinase Inhibitors Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and Plasminogen Activator Inhibitor Type 1 (PAI-1) Are Complementary in Determining Prognosis in Primary Breast Cancer

Molecular & cellular proteomics, 2003-03, Vol.2 (3), p.164-172

2003

Link zum Volltext

Verfügbarkeit prüfen

Measurement of the Uncomplexed Fraction of Tissue Inhibitor of Metalloproteinases-1 in the Prognostic Evaluation of Primary Breast Cancer Patients

Molecular & cellular proteomics, 2005-04, Vol.4 (4), p.483-491

2005

Link zum Volltext

Verfügbarkeit prüfen

P4-01-17: TIMP-1 Over-Expression Confers Resistance of MCF-7 Breast Cancer Cells to Fulvestrant

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P4-P4-01-17

2011

Link zum Volltext

Verfügbarkeit prüfen

Validation of the predictive value of tissue inhibitor of metalloproteinases-1 for the response to first-line chemotherapy in metastatic breast cancer

31st Annual San Antonio Breast Cancer Symposium,2008-12-10 - 2008-12-14, 2009, Vol.69 (2), p.363

2009

Link zum Volltext

Verfügbarkeit prüfen

22 Total tumour tissue levels of tissue inhibitor of metalloproteinases-1 as a prognostic marker in breast cancer: an EORTC validation study of 2984 patients

European journal of cancer supplements, 2003-09, Vol.1 (5), p.S10-S10

2003

Link zum Volltext

Verfügbarkeit prüfen

Tissue inhibitor of metalloproteinases-1 (TIMP-1) and prognosis in primary breast cancer: an EORTC—RBG collaborative validation study including 2984 patients

European journal of cancer supplements, 2004-03, Vol.2 (3), p.170-170

2004

Link zum Volltext

Verfügbarkeit prüfen

Levels of tissue inhibitor of metalloproteinases 1 in plasma and urine from patients with bladder cancer

The International journal of biological markers, 2006, Vol.21 (1), p.6-11

2006

Link zum Volltext

Verfügbarkeit prüfen

TIMP-1 as a new cancer biomarker: From bench to bed and back again

INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2007, Vol.22 (1), p.55

2007

Link zum Volltext

Verfügbarkeit prüfen

Human epidermal growth factor receptor 2 (HER2) immunoreactivity: specificity of three pharmacodiagnostic antibodies

Histopathology, 2011-11, Vol.59 (5), p.975-983

2011

Link zum Volltext

Verfügbarkeit prüfen

Banking of Biological Fluids for Studies of Disease-associated Protein Biomarkers

Molecular & cellular proteomics, 2008-10, Vol.7 (10), p.2061-2066

2008

Link zum Volltext

Verfügbarkeit prüfen

TIMP-1 as a tumor marker in breast cancer - An update

Acta oncologica, 2008, Vol.47 (4), p.580-590

2008

Link zum Volltext

Verfügbarkeit prüfen

The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells

BMC genomics, 2016-06, Vol.17 (1), p.442-442, Article 442

2016

Link zum Volltext

Verfügbarkeit prüfen

Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines

BMC cancer, 2016-01, Vol.16 (26), p.34-34, Article 34

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(40)
Tagungsberichte
(2)

Sprache

Englisch
(42)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Humans
(25)
Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Female
(20)
Oncology
(15)
Breast Cancer
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Breast Neoplasms - Pathology
(9)
Enzyme-Linked Immunosorbent Assay
(9)
Middle Aged
(9)
Prognosis
(9)
Tissue Inhibitor Of Metalloproteinase-1 - Metabolism
(9)
Breast Neoplasms - Metabolism
(8)
Adult
(7)
Aged
(7)
Tissue Inhibitor Of Metalloproteinase-1 - Blood
(7)
Tumors
(7)
Breast Neoplasms - Diagnosis
(6)
Breast Neoplasms - Genetics
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tissue inhibitor of metalloproteinases-1 in breast cancer

Evaluation of sample handling in relation to levels of tissue inhibitor of metalloproteinases-1 measured in blood by immunoassay

Investigation of tissue inhibitor of metalloproteinases 1 in plasma from colorectal cancer patients and blood donors by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry

Evaluation of sample handling in relation to levels of tissue inhibitor of metalloproteinases-1 measured in blood by immunoassay

Levels of tissue inhibitor of metalloproteinases 1 in plasma and urine from patients with bladder cancer

Tissue inhibitor of metalloproteinases-1 protects the human breast carcinoma cell line MCF-7 S1 against anthracycline-induced cell death by activation of the akt survival pathway

Abstract P4-07-04: Preoperative Plasma Concentration of MMP-9/TIMP-1 Complexes Is Not Associated with Disease Outcome in Primary Breast Cancer (N=483)

Abstract P4-08-08: Cross Reactivity of Clinically Validated Anti-HER2 Antibodies

Tumor Tissue Levels of Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Marker in Primary Breast Cancer

Tumor tissue levels of tissue inhibitor of metalloproteinases-1 (TIMP-1) and survival following adjuvant chemotherapy in pre-menopausal lymph node-positive breast cancer patients (N=525)

Validation of the predictive value of tissue inhibitor of metalloproteinases-1 for the response to first-line chemotherapy in metastatic breast cancer

Tumor markers: from laboratory to clinical utility

Tumor Tissue Concentrations of the Proteinase Inhibitors Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and Plasminogen Activator Inhibitor Type 1 (PAI-1) Are Complementary in Determining Prognosis in Primary Breast Cancer

Measurement of the Uncomplexed Fraction of Tissue Inhibitor of Metalloproteinases-1 in the Prognostic Evaluation of Primary Breast Cancer Patients

P4-01-17: TIMP-1 Over-Expression Confers Resistance of MCF-7 Breast Cancer Cells to Fulvestrant

Validation of the predictive value of tissue inhibitor of metalloproteinases-1 for the response to first-line chemotherapy in metastatic breast cancer

22 Total tumour tissue levels of tissue inhibitor of metalloproteinases-1 as a prognostic marker in breast cancer: an EORTC validation study of 2984 patients

Tissue inhibitor of metalloproteinases-1 (TIMP-1) and prognosis in primary breast cancer: an EORTC—RBG collaborative validation study including 2984 patients

Levels of tissue inhibitor of metalloproteinases 1 in plasma and urine from patients with bladder cancer

TIMP-1 as a new cancer biomarker: From bench to bed and back again

Human epidermal growth factor receptor 2 (HER2) immunoreactivity: specificity of three pharmacodiagnostic antibodies

Banking of Biological Fluids for Studies of Disease-associated Protein Biomarkers

TIMP-1 as a tumor marker in breast cancer - An update

The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells

Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines

Suchergebnisse filtern